Bastard P, Adrian G, Taniguchi M, Saare L, Särekannu K, Voyer TL, Philippot Q, Rosain J, Bizien L, Asano TA, Garcia-Prat M, Parra-Martínez A, Migaud M, Tsumura M, Conti F, Belot A, Rivière JG, Morio T, Tanaka J, Javouhey E, Haerynck F, Duvlis S, Ozcelik T, Keles S, Redondo YT-L, Escoda S, Husain M, Pan-Hammarström Q, Hammarström L, Ahlijah G, Haidar AA, Soudee C, Arsegue V, Abolhassani H, Sahanic S, Tancevsk I, Nukui Y, Hayakawa S, Chrousos GP, Michos A, Tatsi E-B, Filippatos F, Seuma AR-P, Garcia JT, Tipu I, Meyts I, Roussel L, Ostrowski SR, Schidlowski L, Prando C, Cheikh N, Bousfiha AA, Bakkouri JE, Peterson P, Pujol A, Lévy R, Quartier P, Vinh DC, Boisson B, Béziat V, Zhang S-Y, Borghesi A, Pession A, Andreakos E, Marr N, Mentis A-FA, Mogensen TH, Rodríıguez-Gallego C, Soler-Palacín P, Colobran R, Tillmann V, Neven B, Trouillet-Assant S, Brodin P, Abel L, Jouanguy E, Zhang Q, Martinón-Torres F, Ellacuriaga AS, Gómez-Carballa A, Gonzalez-Granado LI, Kisan K, Okada S, Puel A, Cobat A, Casanova J-L, Condino Neto A. Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children [Internet]. The Journal of Experimental Medicine. 2024 ; 221( 2): 45 .[citado 2024 jun. 18 ] Available from: https://doi.org/10.1084/jem.20231353
